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Abstract
Objective: The population-based “Asymptomatic Polyvascular Abnormalities in Community (APAC) Study was
designed to examine prevalence and associations of asymptomatic polyvascular abnormalities (APA) in a general
population. In this report, the objectives, design and baseline data of the APAC study are described.
Methods: The study included 5,440 participants (40.1% women) with an age of 40+ years who were randomly
selected from the population of the Kailuan Study which included 101,510 employees and retirees of the Kailuan Co.
Ltd, a large coal mine industry located in Tangshan, Hebei, China. Exclusion criteria were previous cerebral stroke,
transient ischemic attacks and coronary heart disease. In 2010 and 2011, information on potential cardiovascular risk
factors was collected and all participants underwent transcranial Doppler sonography, measurement of the ankle
brachial index, and bilateral carotid duplex sonography. In a first follow-up examination in 2012/2013, retinal
photography and spectral-domain optical coherence tomography were additionally performed. In a planned long-term
follow-up, data from clinical examinations and laboratory tests and the occurrence of cardiovascular or
cerebrovascular events will be collected to build up a predicting model for the risk of ischemic events.
Results: At baseline, mean age of the participants was 55.2±11.8 years, and men showed a significantly (P<0.001)
higher prevalence of arterial hypertension (55.5% vs. 36.5%) and hyperlipidemia (50.7% vs. 46.0%) and a higher
blood homocysteine concentration (18.68±10.28µmol/L versus 11.69±6.40µmol/L).
Conclusions: The APAC is the first study to prospectively evaluate the relationship between intracranial arterial
stenosis, retinal nerve fiber layer changes, retinal microvascular signs, and the eventual development of
cerebrovascular or cardiovascular events.
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Introduction
Stroke is the leading cause of death in China and accounts
for approximately 20% of all deaths causes [1]. Intracranial
arterial stenosis (ICAS) of major arteries in the brain is one of
the most common pathomechanisms for the development of an
ischemic stroke [2-4]. In view of the potentially devastating
consequences of an ischemic stroke, its prevention is of high
importance. Prevention includes detecting patients at risk of
eventually developing an ischemic attack [5]. Recent
population-based studies have applied transcranial Doppler
sonography (TCD) to diagnose an intracranial arterial stenosis
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[6-13]. Other studies have shown that retinal microvascular
abnormalities such as focal arteriolar narrowing and
arteriovenous nicking and retinopathy signs such as retinal
hemorrhages and cotton-wool spots have prognostic
importance to predict the eventual development of a cerebral
stroke [14-17].
Recently, localized defects of the retinal nerve fiber layer
(RNFLD), in addition to retinal microvascular abnormalities,
have been described to be associated with different grades of
arterial hypertension. In a recent study on 359 arterial
hypertensive patients and 331 arterial normotensive
individuals, the odds ratios for the association between
localized RNFLDs and various grades of arterial hypertension
were higher than the odds ratios for the association between
the retinal microvascular abnormalities and the grades of
arterial hypertension [18]. Other, hospital-based and
population-based studies have revealed correlations between a
diffuse thinning of the retinal nerve fiber layer (RNFL) and non-
glaucomatous optic nerve damage the causes of which
included cerebrovascular events [19-21]. The RNFL can be
examined by simple ophthalmoscopy in daily practice and it
can be measured by optical coherence tomography (OCT)
which allows the detection of localized RNFLDs and the
quantification of a diffuse thinning of the RNFDL [19,21].
In view of the relative easiness of the assessment of the
RNFL, also by a non-ophthalmologist, and in view of that the
association between the status of the intraocular RNFL as
developmental part of the brain and the incidence of
cerebrovascular events has not been explored yet, we
designed the APAC to evaluate in a cross-sectional manner the
relationship between the status of the RNFL and ICAS; and to
examine longitudinally the correlation between the RNFL status
and the incidence of cerebrovascular events. Additional goals
are to examine in a cross-sectional manner and in a
longitudinal manner the correlations between retinal
microvascular abnormalities and the cerebrovascular status as
assessed by TCD with particular emphasis on ICAS; and to
compare the diagnostic and prognostic value of the RNFL
status parameters with the diagnostic precision of the retinal
microvascular abnormalities to forecast a cerebrovascular
insult. The current report describes the design, rationale and
baseline information of APAC.
Methods
Ethics Statement
The study was performed according to the guidelines of
Helsinki Declaration and was approved by both the Ethics
Committee of the Kailuan General Hospital, Beijing Tongren
Hospital and Beijing Tiantan Hospital. The approval will be
renewed every 5 years. Written informed consent was obtained
from all participants.
Study Design and Population
The Asymptomatic Polyvascular Abnormalities Community
study (APAC) is a community-based, prospective, long-term
follow-up observational study, to investigate the epidemiology
of asymptomatic polyvascular abnormalities in Chinese adults.
The study cohort was a sub-population of a previously
described population of the Kailuan study which included a
total of 101,510 employees and retirees (81,110 men) of the
Kailuan (Group) Co. Ltd, a large coal mine industry located in
Tangshan, Hebei Province (Figure 1) [22]. The city of
Tangshan with approximately 7.2 million inhabitants in 2006 is
situated 150 km southeast of Beijing and is a center of the coal
mining industry. From June 2010 to June 2011, a sample of
7000 subjects older than 40 years was randomly selected from
the Kailuan cohort, using a stratified random sampling method
by age and gender based on the data of the Chinese National
Census from 2010. The sample size was calculated based on
detection of a 7% event rate with 0.7% precision and an α
value of 0.05. The response rate was assumed to be >80%. A
total of 5,852 subjects agreed to participate in the APAC study
and 5,816 people eventually completed the baseline data
collection. Among these 5,816 individuals, 376 subjects did not
meet the following inclusion criteria (1) no history of stroke,
transient ischemic attack, and coronary disease at baseline as
assessed by a validated questionnaire; and (2) absence of
neurologic deficits for stroke which was estimated by
experienced doctors. Finally, a total of 5,440 participants were
eligible and were included into APAC study.
Assessment of ICAS
Transcranial Doppler was performed by two experienced
neurologists with portable examination devices (EME
Companion, Nicolet, Madison, WI, USA). ICAS was diagnosed
according to the peak flow velocity based on published criteria
[7,19]. An arterial stenosis was defined by a peak systolic flow
velocity of >140 cm/s for the middle cerebral artery, of >120
cm/s for the anterior cerebral artery, >100 cm/s for the posterior
cerebral artery and vertebra-basilar artery, and >120 cm/s for
the siphon internal carotid artery. In addition, the presence of
turbulences or sound and the location of an abnormal blood
flow velocity in a segment of a vessel or along the whole vessel
were noted. In the absence of temporal windows, the
examination was performed through the orbits to locate
intracranial signals [23]. Subjects with poor insonation windows
were considered as having no stenosis.
Assessment of Retinal Photography
All study participants underwent fundus photography using a
non-mydriatic digital fundus camera (fundus camera Type
CR6-45NM; Canon, Ōta, Tokyo, Japan). Simultaneous
stereoscopic 45° color fundus photographs centered on the
optic disc (Diabetic Retinopathy Study standard field 1) and on
the macula (Diabetic Retinopathy Study standard field 2) were
taken for each eye. Using the fundus photographs and applying
the protocol of the Atherosclerosis Risk in Communities study,
we assessed the retinal vascular abnormalities of generalized
retinal arteriolar narrowing, focal arteriolar narrowing,
arteriovenous nicking and isolated retinopathy lesions
(microaneurysms, cotton wool spots, retinal hemorrhages, or
hard exudates) [24]. To assess generalized retinal vascular
changes, the retinal vessel diameters were measured using
computer assisted quantitative assessment software (IVAN;
University of Wisconsin, Madison, WI), as described and
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Figure 1.  Flowchart of the Asymptomatic Polyvascular Abnormalities in Community (APAC) Study.  
doi: 10.1371/journal.pone.0084685.g001
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applied in previous population-based studies [25]. Average
retinal arteriolar or venular width was calculated by means of
the Parr–Hubbard formula and was presented as the central
retinal arteriolar equivalent or central retinal venular equivalent.
The arteriovenous ratio was calculated as central retinal
venular equivalent divided by the central retinal arteriolar
equivalent. Generalized retinal arteriolar narrowing was defined
as an arteriovenous ratio less than the lowest quartile of the
arteriovenous ratio value in the normal control group [26]. The
procedure has been described in detail elsewhere [27].
Arteriolar focal narrowing was considered to be present if the
involved vessel had a diameter of at least 50 um or
approximately one third the diameter of a major vein at the disc
margin and if the narrowed part of the vessel had a caliber less
than or equal to two-thirds of the caliber of the proximal and
distal arterial segments. Arteriovenous nicking was present if
there was a tapering or narrowing of the venous blood column
on both sides of an arteriovenous crossing. Arteriovenous
crossings located within half an optic disc diameter of the disc
margin were excluded because, in that region, the vein usually
crossed over the artery. Isolated retinopathy lesions
(microaneurysms, cotton wool spots, retinal hemorrhages, and
hard exudates) were graded as either present or absent.
Presence of retinal emboli and presence of retinal vein
occlusion was also assessed. Retinal emboli were
intravascular lesions seen either along the course of retinal
arterioles or at a bifurcation. They were graded as cholesterol
(reflective or refractile), fibrin-platelet (dull) or calcific (chalky
white) [28]. Recent central retinal vein occlusion was
characterized by the presence of retinal edema, optic disc
hyperemia or edema, scattered superficial or deep
hemorrhages, and venous dilatation. Old retinal vein occlusions
were characterized by occluded and sheathed retinal veins.
Branch retinal vein occlusion involved a more localized area of
the retina in the sector of the obstructed venule and was
characterized by scattered superficial and deep retinal
hemorrhages, venous dilatation, intraretinal microvascular
abnormalities, and occluded and sheathed retinal venules. An
ischemic type of vein occlusion was characterized by retinal
neovascularization that was distinguished from intraretinal
collateral vessel formation between an occluded and non-
occluded region, in the case of branch retinal vein occlusions,
or by very thin retinal vessels in the affected region [29].
Assessment of Spectral-Domain Optical Coherence
Tomography (SD-OCT)
SD-OCT images of the optic nerve head, macula and
adjacent retina were obtained using a portable spectral-domain
OCT system (iVue SD-OCT; Optovue Inc, Fremont, California,
USA). The iVue SD-OCT used a superluminescent diode scan
with a center wavelength of 840 ± 10 nm to provide high
resolution images. A 6 x 6 mm2 raster scan was centered on
the optic disc and macula. Each raster was composed of 101
B-scans each of which included 512 A-scans (acquisition time,
2.2 seconds). All OCT scans were obtained through undilated
pupils. Quality assurance checks were carried out. Images with
RNFL segmentation algorithm failures, motion artifacts, poor
focusing or a scan score index <40 and images not centered
were excluded from the assessment. Two experienced
examiners (JL YL) scanned all study participants.
Measurements of both eyes of each study participant were
taken in a sitting position. For further analysis, we used the
average RNFL thickness, the mean RNFL thickness in each
quadrant, and the mean RNFL thickness in each of the twelve
30° clock-hour sectors.
Assessment of Extracranial Arterial Stenosis (ECAS)
Each participant underwent a bilateral carotid duplex
ultrasound to evaluate for carotid stenosis as a part of standard
diagnostic workup. Carotid stenosis (≥50%) was graded based
on recommendations from The Society of Radiologists in
Ultrasound Consensus Conference [30].
Assessment of Peripheral Arterial Disease (PAD)
The ankle brachial index (ABI) measurement was calculated
using a standard method [31]. Systolic blood pressure was
measured with a handheld 5-MHz Bidirectional Doppler probe
(Hokanson MD6 Doppler with MD6VR Chart Recorder;
Bellevue, Wash). Pressures in each leg were determined and
the ABI was calculated separately for each leg. An ABI <0.90 in
either leg was considered as marker for the presence of a
PAD, and an ABI ≥0.90 was considered normal. Elevated ABI
values of ≥1.40 suggested poorly compressible leg arteries and
were excluded from the statistical analysis.
Assessment of Demographic Variables and
Cardiovascular Risk Factors
Information on demographic variables (e.g., age, gender,
household income, level of education, and previous history of
diseases) was collected through questionnaires. The
participants were stratified by age into two categories: 40-59
years old and ≥60 years old. The average monthly income of
every family member was reported as “<¥1,000” ,
“¥1,000-3,000” or “≥¥3,000”. The level of education was
categorized as “illiteracy or primary school”, “middle school” or
“high school or higher”. Information regarding previous history
of diseases mainly contained arterial hypertension and
dyslipdemia. Information on smoking, physical activity and
dietary intake were collected by questionnaires. The smoking
status was classified as “never”, “former”, or “current”
according to self-reported information. Physical activity was
classified as very active (exercise >80min/week), moderately
active (exercise: 1~80min/week) or inactive (exercise: none).
Salt intake was classified as low (salt: <6g/day), medium (salt:
6~10g/day) or high (salt: >10g/day).
Body weight (to the nearest 0.1 kg) and body height (to the
nearest 0.1 cm) were measured, and the body mass index
(BMI) was calculated as body weight (kg) divided by the square
of height (m2). Blood pressure was determined to the nearest 2
mm Hg using a mercury sphygmomanometer with a cuff of
appropriate size. Two readings of systolic blood pressure
(SBP) and diastolic blood pressure (DBP) were taken at a five-
minute interval. The average of the two readings was used for
the current data analysis. If the two measurements differed by
more than 5 mm Hg, an additional reading was taken, and the
average of the three readings was used. BMI was divided into
Asymptomatic Polyvascular Abnormalities
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categories of <25 kg/m2 , 25 to 29.9 kg/m2, or ≥30 kg/m2.
Arterial hypertension was defined based on the following
information alone or in combination: 1) as presence of a history
of arterial hypertension; 2) using antihypertensive medication;
or 3) a systolic blood pressure ≥140 mm Hg, or a diastolic
blood pressure of ≥90 mm Hg. Diabetes mellitus was defined
as a self-reported history, current treatment with insulin or oral
hypoglycemic agents, or fasting blood glucose level ≥126
mg/dl. Dyslipidemia was defined by a self-reported history,
current use of cholesterol lowering medicine, or a total
cholesterol level ≥220 mg/dl or triglyceride ≥150 mg/dl or low
density lipoprotein ≥160 mg/dl.
Genetic and Biomarker Data Collection
At each examination Blood samples were collected from the
antecubital vein in the morning under fasting conditions. They
were stored in vacuum tubes containing EDTA (Ethylene
DiamineTetraacetic Acid) for storage. Fasting blood glucose
was measured with the hexokinase/ glucose-6-phosphate
dehydrogenase method. Cholesterol and triglyceride
concentrations were measured enzymatically (inter-assay
coefficient of variation: < 10% (Mind Bioengineering Co. Ltd,
Shanghai, China)). Blood samples were also measured using
an auto-analyzer (Hitachi 747; Hitachi, Tokyo, Japan) at the
central laboratory of the Kailuan General Hospital. For all
participants, serum creatinine, cholesterol, high-density
lipoproteins (HDL-C), low-density lipoproteins (LDL-C),
triglycerides and glucose levels were assessed. In subgroup
analysis studies, various biomarkers of blood cells, serum and
plasma were measured including the C-reactive protein,
homocysteine, steroids (e.g. estrogens, androgens, vitamin D,
Lp-PLA2), insulin and glycosylated hemoglobin HbA1c.
Follow-Up and Outcome Assessment
The study participants will be followed up by face-to-face
interviews once every two years in a routine medical
examination up to December 31, 2015, or up to the occurrence
of a final event as defined in the study, or occurrence of death.
The follow-ups are performed by physicians and nurses who
are masked to the baseline data. The outcome information for
subjects not participating in the follow-up examination is
obtained by checking death certificates from provincial vital
statistics offices, discharge summaries from the 11 hospitals,
and medical records from the medical insurance.
The primary outcome is the first occurrence of stroke, either
the first non-fatal stroke event or death by stroke. A non-fatal
stroke is defined as a focal neurological deficit of vascular
origin and of sudden onset and which lasts >24 hours. Stroke is
diagnosed according to the World Health Organization (WHO)
criteria combined with brain computed tomography (CT) or
magnetic resonance (MR) confirmation, and classified into
three main types: brain infarction, intracerebral hemorrhage,
and subarachnoid hemorrhage [32]. The criteria are consistent
across all participating hospitals.
All stroke records are reviewed by two independent stroke
specialists. If the two specialists disagree, the event
adjudication committee reviews the case and makes the final
decision. All stroke outcomes are checked by the Data Safety
Monitoring Board and Arbitration Committee for Clinical
Outcomes.
The first occurrence of coronary heart disease is an
additional outcome event. Incident coronary heart disease is
defined as the occurrence of a fatal or non-fatal myocardial
infarction (I21), other forms of acute (I24) or chronic ischemic
(I25) heart disease, sudden (cardiac) death (I46 and R96),
death caused by ventricular fibrillation (I49), or death resulting
from congestive heart failure (I50) during follow-up [33]. Other
outcomes include heart failure and atrial fibrillation [34,35].
Data Management and Statistical Analyses
The data management system including the statistical
analysis is performed using the SAS software (version 9.1;
SAS Institute, Cary, North Carolina, USA) or the SPSS
software (SPSS for Windows, version 21.0, IBM-SPSS,
Chicago, IL). As first step, the distributions (mean ± standard
deviation) of the parameters are calculated. The normal
distribution of the parameters is assessed using the
Kolmogorov-Smirnoff test. As second step, the parameters are
compared between the groups, using either the student’s t test
for paired or non-paired samples of normally distributed
parameters or the Wilcoxon-Mann-Whitney test or the Wilcoxon
test for non-parametric variables. The Chi-squared test is
applied for the comparison of categorical variables. As third
step of the analysis, multivariate associations between the
various parameters will be performed using multivariable
regression analyses or binary regression analyses. As fourth
step, a longitudinal assessment of associations and a survival
analysis for the combination of major vascular events and for
each vascular event will be performed using the Kaplan-Meier
curves in relation to the presence/absence of intracranial
stenosis, retinal microvascular abnormalities, retinopathy signs
and RNFL defects. Cox multivariate regression models will be
used to compare the probability of having a vascular event in
the follow-up cohorts, adjusting for the necessary covariates.
The relative risk (hazards ratios) will be presented with their
corresponding 95% confidence intervals. The level for
statistical significance will be set at α = 0.05 (two -tailed).
Results
A total of 5440 subjects (2183 (40.1%) women) were
enrolled in the APAC study. The basic characteristics of the
study population including age, level of education, income level
and previous disease history were described and compared.
Women were younger and had a higher level of education
compared to men (P<0. 001), while men showed a higher
prevalence of arterial hypertension (55.5% versus 36.5%) and
hyperlipidemia (50.7% versus 46.0) (Table 1).
The prevalence of risk factors for asymptomatic polyvascular
abnormalities (APA) such as smoking, BMI, physical activity,
salt intake and the homocysteine level differed significantly
between men and women, while both gender did not vary
significantly in high-sensitive C-reactive protein concentration
(Table 2). Specifically, smoking was significantly more
prevalent in men than women (31.9% versus 1.8%; P<0.01).
BMI index was higher in women than in men for the age group
Asymptomatic Polyvascular Abnormalities
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of <25 years, whereas it was higher in men than women for the
age group of 25 to 30 years. There was no significant
difference between gender in BMI for the age groups of >30
years (Table 2). Homocysteine levels were categorized into 4
quartiles as shown in Table 2. Men as compared with women
were significantly found more often in the higher 3rd and 4th
quartiles, and consequently had significantly higher mean
values 18.68 ± 10.28 µmol/L versus 11.69 ± 6.4 µmol/L) (Table
2).
Discussion
More than 7 million Chinese currently suffer from the
sequelae of stroke, with another 2 million subjects newly
diagnosed and 1.4 million Chinese affected by a recurrence of
stroke each year [1]. Intracranial arterial stenosis of the major
arteries is the most common factor leading to ischemic stroke
worldwide. Intracranial arterial stenosis is not an isolated
disease, but it is related to generalized atherosclerosis
affecting other body regions such as the carotid artery, the
coronary artery or peripheral arteries [36,37]. Table 3
compares previous studies on intracranial stenosis [38-43].
Classic vascular risk parameters have now been combined
with new markers as carotid intima-media thickness, ankle-arm
index or high sensitive C-reactive protein values to assess the
individual vascular risk. Prior to the occurrence of a stroke,
most patients may already have pathological changes in their
intracranial arteries, even though these changes can be
asymptomatic.
Similarities between the retinal and cerebral small vessels
suggest that examination of the relationship between retinal
microvascular abnormalities and stroke and its subtypes may
help understanding the etiology of stroke and risk for stroke.
Data from various large population-based cohorts have
Table 1. Baseline Demographic Characteristics (Mean ±
Standard Deviation) of the Asymptomatic Polyvascular
Abnormalities in Community (APAC) Study Stratified by
Gender.
 Total Women Men P-Value
n 5440 2183 3257  
Age (Years) 55.17 ± 11.79 52.3 ± 9.73 57.1 ± 12.62 <0.001
Education (n, %)
Illiteracy / Primary School 662 (12.2) 185 (8.5) 477 (14.6) <0.001
Middle School 2394 (44) 878 (40.2) 1516 (46.6)  
High School or Higher 2383 (43.8) 1120 (51.3) 1263 (38.8)  
Income (n, %)*
<¥1,000 1153 (21.2) 462 (21.2) 691 (21.2) <0.001
¥1,000-3,000 3595 (66.1) 1570 (71.9) 2025 (62.2)  
≥¥3,000 690 (12.7) 151 (6.9) 539 (16.6)  
Previous History of Disease
Arterial Hypertension (n, %) 2604 (47.9) 796 (36.5) 1808 (55.5) <0.001
Diabetes mellitus (n, %) 655 (12) 216 (9.9) 439 (13.5)  
Dyslipidemia (n, %) 2655 (48.8) 1005 (46.0) 1650 (50.7)  
P-Value: Statistical significance of difference between men and women
doi: 10.1371/journal.pone.0084685.t001
provided new insights into the prognostic value of retinal
microvascular signs. The Atherosclerosis Risk in Communities
(ARIC) was a prospective US population-based community
study of 15,792 individuals aged 45–64 years with 86% of the
cohort having retinal photography performed at the third follow-
up [17]. The Blue Mountains Eye Study was an Australian
population-based cohort study including participants 49 years
of age or older [28]. The Rotterdam Scan Study was a Dutch
population-based cohort study in which 6780 subjects
participated in the ophthalmic part of the study [16]. The US-
based Cardiovascular Health study assessed retinal
photographs of about 4000 persons [44]. The Beaver Dam Eye
Study in Wisconsin examined retinal vascular signs in persons
43–84 years of age [45]. These studies demonstrated that
retinal microvascular signs were associated not only with
stroke risk factors (e.g. arterial hypertension) [46,47] and
history of vascular disease [48], but were also independently
related to a variety of other vascular risk factors [49] and
important outcomes such as incident stroke [17,22], subclinical
cerebral infarct [24], white matter abnormalities on magnetic
resonance imaging (MRI) [16] and cognitive impairment [50].
Other studies of patients with symptomatic atherosclerotic
Table 2. Distribution of Risk Factors in APAC Stratified by
Gender.
 Total (n, %) Women (n, %)  Men (n, %) P-Value
Smoking
Never 3400 (62.5) 2137 (97.9) 1263 (38.8) <0.01
Former 303 (5.6) 7 (0.3) 296 (9.1)  
Current 1737 (31.9) 39 (1.8) 1698 (52.1)  
Body Mass Index (kg/m2)
<25 2907 (53.4) 1251 (57.3) 1656 (50.8) <0.01
25 to 29.9 2178 (40.0) 783 (35.9) 1395 (42.8)  
≥30 355 (6.5) 149 (6.8) 206 (6.3)  
Physical Activity
Very Active 2178 (40.0) 827 (37.9) 1351 (41.5) <0.01
Moderately Active 1388 (25.5) 658 (30.1) 730 (22.4)  
Inactive 1874 (34.4) 698 (32.0) 1176 (36.1)  
Salt intake
Low 1135 (20.9) 535 (24.5) 600 (18.4) <0.01
Medium 3242 (59.6) 1309 (60.0) 1933 (59.3)  
High 1063 (19.5) 339 (15.5) 724 (22.2)  
High-Sensitive C-Reactive Protein (mg/L, median)
1st tile(<0.5) 1277 (23.5) 487 (22.3) 790 (24.3) 0.03
2st tile(0.5~1.0) 1442 (26.5) 623 (28.5) 819 (25.1)  
3st tile(1.0~2.2) 1379 (25.3) 534 (24.5) 845 (25.9)  
4st tile(>2.2) 1342/ (24.7) 539 (24.7) 803 (24.7)  
Homocysteine (µmol/L)
1st tile(<9.6) 1376 (25.3) 910 (41.7) 466 (14.3) <0.01
2st tile(9.6~13.6) 1344 (24.7) 635 (29.1) 709 (21.8)  
3st tile(13.6~19.3) 1357 (24.9) 415 (19.0) 942 (28.9)  
4st tile(>19.3) 1363 (25.1) 223 (10.2) 1140 (35.0)  
Mean ± Standard
Deviation 15.87 ± 9.56 11.69 ± 6.40 18.68 ± 10.28 <0.01
P-Value: Statistical significance of difference between men and women
doi: 10.1371/journal.pone.0084685.t002
Asymptomatic Polyvascular Abnormalities
PLOS ONE | www.plosone.org 6 December 2013 | Volume 8 | Issue 12 | e84685
disease (recent ischemic stroke, myocardial infarction, or
peripheral arterial disease) demonstrated that retinal arteriolar
narrowing as defined from retinal photographs was related to
the presence of white matter lesions and lacunar infarcts
detected on MRI [51]. Other researchers reported that retinal
microvascular blood flow was reduced in persons with white
matter lesions and lacunar infarction [52], and that the
histopathology of retinal arterioles and cerebral arterioles was
similar in patients with stroke [53]. Retinal vessels and cerebral
vessels in general share similar anatomic and physiologic
characteristics and changes [54]. Retinal examination may thus
be a surrogate of cerebral vessel examination and the retina
could be considered as a ‘window’ to the cerebral vessels.
Spectral-domain OCT (SD-OCT) permits high-resolution
retinal imaging with resolution of the separate retinal layers and
thuds allows measurement of the thickness of the retinal nerve
fiber layer and the retinal ganglion cell complex. Both layers
forming the first part of the optic nerve have not been evaluated
by SD-OCT to predict the incidence of stroke in a large
epidemiological study.
Since as in any study of a design such as the one of the
APAC, problems may occur with the data collection, in using
the various instruments and in performing the different
procedures, additional steps will be incorporated into the study
design. All examiners involved with measuring the study
parameters will undergo a standardized central training and
certification, and in regular intervals of about 6 months, a re-
certification should follow. This certification process will include
all interviewers and health professionals responsible for the
clinical and laboratory examinations to ensure that the
procedures are performed according to the study protocol. In
addition, the inter-observer reproducibility and intra-observer
reproducibility shall be tested by mixing 10 copies of each of 20
images under the whole volume of samples undergoing the
routine assessment procedure. These 20 images with their
copies will be re-assessed in a masked manner. In general the
measured data will be collected in electronic datafiles which will
daily be copied into a safety datafile.
Potential limitation of our study should be discussed. First,
the study is based on a randomly selected subgroup of the
participants of the large Kailuan Study which includes
employees and retirees of the Kailuan Company. One may
argue that despite its large study sample, the Kailuan Study
population may not be representative for the population of the
city of Tangshan or the province of Hebei. The large sample
size of the study allows however forming subgroups of actual
coal miners, retired coal miners, and office employees. The
study design may therefore enable to examine and compare
the study parameters within a coal miner specific group, to
compare the influence of previous working and lifestyle
conditions with the influence of actual working and lifestyle
conditions (among the retired coal miners), and to assess the
study parameters in an unspecific non-coal mining population
group (office workers and other employees). In addition, the
study population was selected using a stratified random
sampling method by age and gender based on the data of the
Chinese National Census from 2010. Second, a magnetic
resonance imaging of the brain to detect clinically silent strokes
will not routinely be performed. Strength of the study is its size
and the stability and low mobility of the study population what
may facilitate longtime follow-up examinations.
In conclusion, our report describes the rationale, study
hypothesis and methodology of the Asymptomatic Polyvascular
Abnormalities in Community (APAC) Study. In 2010 and 2011,
information on potential cardiovascular risk factors was
collected and all participants underwent transcranial Doppler
sonography, measurement of the ankle brachial index, and
bilateral carotid duplex ultrasound. In a first follow-up
examination in 2012/2013, retinal photography and spectral-
domain optical coherence tomography were additionally
performed. In a planned long-term follow-up, data from clinical
examinations and laboratory tests and the occurrence of
cardiovascular or cerebrovascular events will be collected to
build up a predicting model for the risk of ischemic events. The
APAC is the first study to prospectively evaluate the
relationship between intracranial arterial stenosis, retinal
microvascular signs, retinal nerve fiber layer changes, and the
eventual development of cerebrovascular or cardiovascular
events.
Table 3. General Characteristics of Studies on Asymptomatic Polyvascular Abnormalities.
First Author Sample Size Design Prevalence (%)
Wong KS (2007)[7] 590 Chinese population aged ≥40 years Cross-sectional, population-based 6.9 (ICAS)
Wong KS (2007) [8] 3,057 Chinese patients with at least one vascular riskfactor Cross-sectional, hospital-based 12.6 (MCA stenosis)
Huang HW (2007) [6] 1,068 Chinese subjects aged ≥ 50 years Cross-sectional, pop.-based 5.9 (MCA stenosis )
Uehara T(2005) [49] 425 Japanese asymptomatic patients Cross-sectional, hospital-based 3.5 (ICAS)
Park KY(2006) [50] 835 Korean adults Cross-sectional, hospital-based 3.0 (ICAS)
Elmore EM (2003) [51] 510 asymptomatic persons Cross-sectional ,hospital-based 12.9 (ICAS)
Lopez-Cancio (2012) [52] 933 stroke-free Caucasians Cross-sect. and cohort study, popul.-based 8.6 (ICAS)
Elizabeth Selvin (2004) [53] 2174 participants aged 40 years and older Cross-sectional, population-based 4.3 (PAD)
Marjoleinde Weerd (2010) [54] 23,706 participants population-based studies 0 to 3.1 (ECAS)
APAC study (2012) 5,440 stroke-free Chinese Ongoing cohort study, population-based 13.2 (ICAS); 6.7 (ECAS) 7.8 (PAD)
doi: 10.1371/journal.pone.0084685.t003
Asymptomatic Polyvascular Abnormalities
PLOS ONE | www.plosone.org 7 December 2013 | Volume 8 | Issue 12 | e84685
Acknowledgements
The most important acknowledgement is to the participants in
the study and the members of the survey teams in each of the
11 regional hospitals of Kailuan Medical Group, as well as to
the project development and management teams based at
Beijing Tiantan hospital, Beijing Tongren Hospital, and the
Kailuan Group.
Author Contributions
Conceived and designed the experiments: YZ YL LX JX AW
XG SW WBW XZ JBJ. Performed the experiments: YZ YL LX
JX AW XG SW WBW XZ. Analyzed the data: YZ YL LX JX AW
XG SW WBW XZ JBJ. Contributed reagents/materials/analysis
tools: SW WBW XZ. Wrote the manuscript: YZ YL LX JX AW
XG SW WBW XZ JBJ.
References
1. Liu M, Wu B, Wang WZ, Lee LM, Zhang SH et al. (2007) Stroke in
China: Epidemiology, prevention, and management strategies. Lancet
Neurol 6: 456-464. doi:10.1016/S1474-4422(07)70004-2. PubMed:
17434100.
2. Gorelick PB, Wong KS, Bae HJ, Pandey DK (2008) Large artery
intracranial occlusive disease: a large worldwide burden but a relatively
neglected frontier. Stroke 39: 2396–2399. doi:10.1161/STROKEAHA.
107.505776. PubMed: 18535283.
3. Wong LK (2006) Global burden of intracranial atherosclerosis. Int J
Stroke 1: 158–159. doi:10.1111/j.1747-4949.2006.00045.x. PubMed:
18706036.
4. Sacco RL, Kargman DE, Gu Q, Zamanillo MC (1995) Race ethnicity
and determinants of intracranial atherosclerotic cerebral infarction: the
Northern Manhattan Stroke Study. Stroke 26: 14–20. doi:
10.1161/01.STR.26.1.14. PubMed: 7839388.
5. Naghavi M, Libby P, Falk E, Casscells SW, Litovsky S et al. (2003)
From vulnerable plaque to vulnerable patient: A call for new definitions
and risk assessment strategies: Part I. Circulation 108: 1664-1672. doi:
10.1161/01.CIR.0000087480.94275.97. PubMed: 14530185.
6. Huang HW, Guo MH, Lin RJ, Chen YL, Luo Q et al. (2007) Prevalence
and risk factors of middle cerebral artery stenosis in asymptomatic
residents in Rongqi county, Guangdong. Cerebrovasc Dis 24: 111-115.
doi:10.1159/000103125. PubMed: 17519553.
7. Wong KS, Huang YN, Yang HB, Gao S, Li H et al. (2007) A door-to
door survey of intracranial atherosclerosis in Liangbei county, China.
Neurology 68: 2031-2034. Available online at: doi:10.1212/01.wnl.
0000264426.63544.ee. PubMed: 17548554.
8. Wong KS, Ng PW, Tang A, Liu R, Yeung V et al. (2007) Prevalence of
asymptomatic intracranial atherosclerosis in high-risk patients.
Neurology 68: 2035-2038. doi:10.1212/01.wnl.0000264427.09191.89.
PubMed: 17548555.
9. Bae HJ, Lee J, Park JM, Kwon O, Koo JS et al. (2007) Risk factors of
intracranial cerebral atherosclerosis among asymptomatics.
Cerebrovasc Dis 24: 355-360. doi:10.1159/000106982. PubMed:
17690548.
10. Suri MF, Georgiadis AL, Tariq N, Vazquez G, Qureshi N et al. (2011)
Estimated prevalence of acoustic cranial windows and intracranial
stenosis in the US elderly population: ultrasound screening in adults for
intracranial disease study. Neuroepidemiology 37: 64-71. doi:
10.1159/000327757. PubMed: 21860252.
11. López-Cancio E, Dorado L, Millán M, Reverté S, Suñol A et al. (2012)
The Barcelona-Asymptomatic Intracranial Atherosclerosis (AsIA) study:
prevalence and risk factors. Atherosclerosis 221: 221-225. doi:10.1016/
j.atherosclerosis.2011.12.020. PubMed: 22245037.
12. López-Cancio E, Galán A, Dorado L, Jiménez M, Hernández M et al.
(2012) Biological signatures of asymptomatic extra- and intracranial
atherosclerosis: the Barcelona-AsIA (Asymptomatic Intracranial
Atherosclerosis) study. Stroke 43: 2712-2719. doi:10.1161/
STROKEAHA.112.661702. PubMed: 22798326.
13. Zhang S, Zhou Y, Zhang Y, Gao X, Zhang Q et al. (2013) Prevalence
and risk factors of asymptomatic intracranial arterial stenosis in a
community-based population of Chinese adults. Eur J Neurol 20:
1479-1485. PubMed: 23746073.
14. Wong TY, Klein R, Couper DJ, Cooper LS, Shahar E et al. (2001)
Retinal microvascular abnormalities and incident stroke: the
Atherosclerosis Risk in Communities Study. Lancet 358: 1134–1140.
PubMed: 11597667.
15. Mitchell P, Wang JJ, Wong TY, Smith W, Klein R et al. (2005) Retinal
microvascular signs and risk of stroke and stroke mortality. Neurology
65: 1005–1009. Available online at: doi:10.1212/01.wnl.
0000179177.15900.ca. PubMed: 16217050.
16. Ikram MK, de Jong FJ, Van Dijk EJ, Prins ND, Hofman A et al. (2006)
Retinal vessel diameters and cerebral small vessel disease: the
Rotterdam Scan Study. Brain 129: 182-188. PubMed: 16317022.
17. Cooper LS, Wong TY, Klein R, Sharrett AR, Bryan RN et al. (2006)
Retinal microvascular abnormalities and MRI-defined subclinical
cerebral infarction: the Atherosclerosis Risk in Communities Study.
Stroke 37: 82–86. doi:10.1161/01.STR.0000195134.04355.e5.
PubMed: 16306463.
18. Xu L, Zhou JQ, Wang S, Wang YX, You QS et al. (2013) Localized
retinal nerve fiber layer defects and arterial hypertension. Am J
Hypertens 26: 511-517. doi:10.1093/ajh/hps081. PubMed: 23429477.
19. Zhao L, Wang YX, Zhang W, Zhang JS, Chen CX et al. (2013)
Localized retinal nerve fiber layer defects detected by optical
coherence tomography. The Beijing Eye Study. PLOS ONE 8: e68998.
doi:10.1371/journal.pone.0068998. PubMed: 23894392.
20. Jonas JB, Schiro D (1994) Localized retinal nerve fiber layer defects in
nonglaucomatous optic nerve atrophy. Graefes Arch Clin Exp
Ophthalmol 232: 759–760. doi:10.1007/BF00184280. PubMed:
7890191.
21. Wang YX, Pan Z, Zhao L, You QS, Xu L et al. (2011) Retinal nerve
fiber layer thickness. The Beijing Eye Study 2011. PLOS ONE 8:
e66763.
22. Wu S, Huang Z, Yang X, Zhou Y, Wang A et al. (2012) Prevalence of
ideal cardiovascular health and its relationship with the 4- year
cardiovascular events in a northern Chinese industrial city. Circ
Cardiovasc Qual Outcomes 5: 487–493. doi:10.1161/
CIRCOUTCOMES.111.963694. PubMed: 22787064.
23. Alexandrov AV, Sloan MA, Wong LK, Douville C, Razumovsky AY et
al.. (2007) (207): Practice standards for transcranial Doppler
ultrasound: Part I - test performance. J Neuroimaging 17: 11–18.
PubMed: 17238867.
24. Hubbard LD, Brothers RJ, King WN, Clegg LX, Klein R et al. (1999)
Methods for evaluation of retinal microvascular abnormalities
associated with hypertension/sclerosis in the Atherosclerosis Risk in
Communities Study. Ophthalmology 106: 2269–2280. doi:10.1016/
S0161-6420(99)90525-0. PubMed: 10599656.
25. Hwang JM, Kim TW, Park KH, Kim DM, Kim H (2006) Correlation
between topographic profiles of localized retinal nerve fiber layer
defects as determined by optical coherence tomography and red-free
fundus photography. J Glaucoma 15: 223–228. doi:10.1097/01.ijg.
0000212218.96932.f7. PubMed: 16778645.
26. Sharrett AR, Hubbard LD, Cooper LS, Sorlie PD, Brothers RJ et al.
(1999) Retinal arteriolar diameters and elevated blood pressure: the
Atherosclerosis Risk in Communities Study. Am J Epidemiol 150: 263–
270. doi:10.1093/oxfordjournals.aje.a009997. PubMed: 10430230.
27. Ye C, To E, Weinreb RN, Yu M, Liu S et al. (2011) Comparison of
retinal nerve fiber layer imaging by spectral domain optical coherence
tomography and scanning laser ophthalmoscopy. Ophthalmology 118:
2196–2202. doi:10.1016/j.ophtha.2011.03.035. PubMed: 21762989.
28. Mitchell P, Wang JJ, Li W, Leeder SR, Smith W (1997) Prevalence of
asymptomatic retinal emboli in an Australian urban community. Stroke
28: 63–66. doi:10.1161/01.STR.28.1.63. PubMed: 8996490.
29. Hayreh SS (1983) Classification of central retinal vein occlusion.
Ophthalmology 90: 458-474. doi:10.1016/S0161-6420(83)34530-9.
PubMed: 6877778.
30. Grant EG, Benson CB, Moneta GL, Alexandrov AV, Baker JD et al.
(2003) Carotid artery stenosis: gray-scale and Doppler US diagnosis--
Society of Radiologists in Ultrasound Consensus Conference.
Radiology 229: 340-346. doi:10.1148/radiol.2292030516. PubMed:
14500855.
31. Greenland P, Abrams J, Aurigemma GP, Bond MG, Clark LT et al.
(2000) Prevention conference V: Beyond secondary prevention:
Identifying the high-risk patient for primary prevention: Noninvasive
tests of atherosclerotic burden: Writing group III. Circulation 101: E16-
E22. doi:10.1161/01.CIR.101.1.e16. PubMed: 10618318.
Asymptomatic Polyvascular Abnormalities
PLOS ONE | www.plosone.org 8 December 2013 | Volume 8 | Issue 12 | e84685
32. Stroke—1989 (1989): Recommendations on stroke prevention,
diagnosis, and therapy. Report of the WHO Task Force on Stroke and
other Cerebrovascular Disorders. Stroke 20 (1407-1431)
33. Oei HH, van der Meer IM, Hofman A, Koudstaal PJ, Stijnen T et al.
(2005) Lipoprotein-associated phospholipase a2 activity is associated
with risk of coronary heart disease and ischemic stroke: The Rotterdam
Study. Circulation. 111: 570-575. Available online at: doi:
10.1161/01.CIR.0000154553.12214.CD. PubMed: 15699277.
34. Bleumink GS, Knetsch AM, Sturkenboom MC, Straus SM, Hofman A et
al. (2004) Quantifying the heart failure epidemic: Prevalence, incidence
rate, lifetime risk and prognosis of heart failure the Rotterdam Study.
Eur Heart J 25: 1614-1619. doi:10.1016/j.ehj.2004.06.038. PubMed:
15351160.
35. Heeringa J, van der Kuip DA, Hofman A, Kors JA, van Herpen G et al.
(2006) Prevalence, incidence and lifetime risk of atrial fibrillation: The
Rotterdam Study. Eur Heart J 27: 949-953. PubMed: 16527828.
36. Arenillas JF, Candell-Riera J, Romero-Farina G, Molina CA, Chacón P
et al. (2005) Silent myocardial ischemia in patients with symptomatic
intracranial atherosclerosis: Associated factors. Stroke 36: 1201-1206.
Available online at: doi:10.1161/01.STR.0000166045.12976.af.
PubMed: 15879333.
37. Hoshino A, Nakamura T, Enomoto S, Kawahito H, Kurata H et al.
(2008) Prevalence of coronary artery disease in Japanese patients with
cerebral infarction: Impact of metabolic syndrome and intracranial large
artery atherosclerosis. Circ J 72: 404-408. doi:10.1253/circj.72.404.
PubMed: 18296836.
38. Uehara T, Tabuchi M, Mori E (2005) Risk factors for occlusive lesions
of intracranial arteries in stroke-free Japanese. Eur J Neurol 12:
218-222. doi:10.1111/j.1468-1331.2004.00959.x. PubMed: 15693812.
39. Park KY, Chung CS, Lee KH, Kim GM, Kim YB et al. (2006) Prevalence
and risk factors of intracranial atherosclerosis in an asymptomatic
korean population. J Clin Neurol 2: 29-33. doi:10.3988/jcn.2006.2.1.29.
PubMed: 20396482.
40. Elmore EM, Mosquera A, Weinberger J (2003) The prevalence of
asymptomatic intracranial large-vessel occlusive disease: The role of
diabetes. J Neuroimaging 13: 224-227. doi:
10.1177/1051228403013003004. PubMed: 12889168.
41. López-Cancio E, Dorado L, Millán M, Reverté S, Suñol A et al. (2012)
The Barcelona-Asymptomatic Intracranial Atherosclerosis (AsIA) study:
prevalence and risk factors. Atherosclerosis 221: 221-225. doi:10.1016/
j.atherosclerosis.2011.12.020. PubMed: 22245037.
42. Selvin E, Erlinger TP (2004) Prevalence of and risk factors for
peripheral arterial disease in the united states: Results from the
national health and nutrition examination survey, 1999-2000.
Circulation 110: 738-743. doi:10.1161/01.CIR.0000137913.26087.F0.
PubMed: 15262830.
43. De Weerd M, Greving JP, Hedblad B, Lorenz MW, Mathiesen EB et al.
(2010) Prevalence of asymptomatic carotid artery stenosis in the
general population: An individual participant data meta-analysis. Stroke
41: 1294-1297. doi:10.1161/STROKEAHA.110.581058. PubMed:
20431077.
44. Wong TY, Hubbard LD, Klein R, Marino EK, Kronmal R et al. (2002)
Retinal microvascular abnormalities and blood pressure in older
people: the Cardiovascular Health Study. Br J Ophthalmol 86: 1007–
1013. doi:10.1136/bjo.86.9.1007. PubMed: 12185128.
45. Wong TY, Klein R, Nieto FJ, Klein BE, Sharrett AR et al. (2003) Retinal
microvascular abnormalities and 10-year cardiovascular mortality: a
population-based case–control study. Ophthalmology 110: 933–940.
doi:10.1016/S0161-6420(03)00084-8. PubMed: 12750093.
46. Sharrett AR, Hubbard LD, Cooper LS, Sorlie PD, Brothers RJ et al.
(1999) Retinal arteriolar diameters and elevated blood pressure: the
atherosclerosis risk in communities study. Am J Epidemiol 150:
263-270. doi:10.1093/oxfordjournals.aje.a009997. PubMed: 10430230.
47. Wong TY, Mitchell P (2004) Hypertensive retinopathy. N Engl J Med
351: 2310–2317. doi:10.1056/NEJMra032865. PubMed: 15564546.
48. Mitchell P, Wang JJ, Smith W (2000) Risk factors and significance of
finding asymptomatic retinal emboli. Clin Experiment Ophthalmol 28:
13–17. doi:10.1046/j.1442-9071.2000.00218.x. PubMed: 11345337.
49. Klein R, Sharrett AR, Klein BE, Chambless LE, Cooper LS et al. (2000)
Are retinal arteriolar abnormalities related to atherosclerosis?: The
Atherosclerosis Risk in Communities Study. Arterioscler Thromb Vasc
Biol 20: 1644–1650. doi:10.1161/01.ATV.20.6.1644. PubMed:
10845884.
50. Wong TY, Klein R, Sharrett AR, Nieto FJ, Boland LL et al. (2002)
Retinal microvascular abnormalities and cognitive impairment in
middle-aged persons: the atherosclerosis risk in communities study.
Stroke 33: 1487–1492. doi:10.1161/01.STR.0000016789.56668.43.
PubMed: 12052979.
51. Kwa VIH, van der Sande JJ, Stam J, Tijmes N, Vrooland JL (2002)
Retinal arterial changes correlate with cerebral small-vessel disease.
Neurology 59: 1536-1540. doi:10.1212/01.WNL.0000033093.16450.5C.
PubMed: 12451193.
52. Schneider R, Rademacher M, Wolf S (1993) Lacunar infarcts and white
matter attenuation. Ophthalmologic and microcirculatory aspects of the
pathophysiology. Stroke 24: 1874–1879. doi:10.1161/01.STR.
24.12.1874. PubMed: 8248970.
53. Dozono K, Ishii N, Nishihara Y, Horie A (1991) An autopsy study of the
incidence of lacunes in relation to age, hypertension, and
arteriosclerosis. Stroke 22: 993–996. doi:10.1161/01.STR.22.8.993.
PubMed: 1866767.
54. Patton N, Aslam T, Macgillivray T, Pattie A, Deary IJ et al. (2005)
Retinal vascular image analysis as a potential screening tool for
cerebrovascular disease: a rationale based on homology between
cerebral and retinal microvasculatures. J Anat 206: 319-348. doi:
10.1111/j.1469-7580.2005.00395.x. PubMed: 15817102.
Asymptomatic Polyvascular Abnormalities
PLOS ONE | www.plosone.org 9 December 2013 | Volume 8 | Issue 12 | e84685
